OCHRE

What this means for you

Not registered yet, but its 26 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79452995

Mark type

Word mark

Filed

26 Mar 2026

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceuticals; therapeutic agents; pharmaceuticals and therapeutics for the treatment of liver diseases, cirrhosis, hepatitis, metabolic dysfunction-associated steatohepatitis (MASH), alcoholic liver diseases, liver fibrosis, primary biliary cholangitis, fibrotic diseases and metabolic diseases; pharmaceuticals and therapeutics for the treatment of obesity, sarcopenia, metabolic disorders and muscular disorders; pharmaceuticals and therapeutics for the treatment of conditions affecting the liver; pharmaceuticals and therapeutics for use in the field of metabolics; RNA medicines; RNA synthesis inhibitors; culture media for cultivating human cells and tissue; cells and tissue for medical or clinical use.
• Class 035 — Advertising and business services: Data entry, collection, compilation, analysis and management services; information, advisory and consultancy services relating to all the aforesaid services.
• Class 042 — Scientific and technological services: Software as a service (SaaS); software as a service (SaaS) for use in relation to pharmaceuticals, DNA analysis, genomic phenotyping, pharmaceutical research and drug discovery; application service provider featuring software for use in the visualisation of data; database design; technical data analysis; technical data analysis services in relation to pharmaceuticals, DNA analysis, genomic phenotyping, pharmaceutical research and drug discovery; drug screening for scientific research purposes; scientific and technical modelling services for use in relation to the research, design and development of pharmaceuticals, drugs and medicines; research and development of siRNA and mRNA drugs; pharmaceutical product evaluation; testing of pharmaceuticals; information, advisory and consultancy services relating to all the aforesaid services.
• Class 044 — Medical, beauty and agricultural services: Medical services in relation to cirrhosis, hepatitis, metabolic dysfunction-associated steatohepatitis (mash), alcoholic liver diseases, liver fibrosis, primary biliary cholangitis, fibrotic diseases, metabolic diseases, the treatment of obesity, sarcopenia, metabolic disorders, muscular disorders and the treatment of conditions affecting the liver; provision of medical information about genomic phenotyping and the treatment of conditions affecting the liver; provision of medical information and data for use in relation to the research, design and development of pharmaceuticals, drugs and medicines; information, advisory and consultancy services relating to all the aforesaid services.

Owner

• Ochre Bio Ltd, GB

Prosecution history

• 08 Oct 2026 — REFUSAL PROCESSED BY IB
• 24 Sept 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 24 Sept 2026 — REFUSAL PROCESSED BY MPU
• 15 Jul 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 14 Jul 2026 — NON-FINAL ACTION WRITTEN
• 13 Jul 2026 — ASSIGNED TO EXAMINER
• 01 Jul 2026 — APPLICATION FILING RECEIPT MAILED
• 01 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 25 Jun 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB